HK inno N

HK inno N makes prescription medicines, including a treatment for peptic ulcers called K-CAB, Korea's thirtieth domestically developed new drug, as well as health-and-beauty drinks such as Condition and Hericium water.

Its prescription medicines reach patients through hospitals and clinics in Korea and through licensing and distribution partners in markets including China, the United States, India, and Latin America. Listed on KOSDAQ, Korea's tech and small-cap board, the company earns the large majority of its revenue from its prescription-medicine division, with its health-and-beauty segment making up a much smaller share.